Sábado, 5 de Dezembro de 2020 20h00/20h45 | Channel 16 (Virtual Meeting) Emicizumab’s Impact on the Landscape of Hemophilia A
Treatment: Two Artists Debate the View - Live Q&A
Stacy E. Croteau, MD, Boston Children’s Hospital
Guy Young, MD, Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine
Robert F. Sidonio Jr., MD, MSc., Children’s Hospital of Atlanta
SINOPSE This session contrasts the potential for favorable clinical and patient outcomes when incorporating emicizumab into patient management with the potential consequences focusing on specific hemophilia A subgroups. Speakers will highlight current data, considerations for clinical decision-making, and gaps in available information in a number of clinical situations including: previously untreated patients (PUPs), managing new FVIII inhibitors patients and immune tolerance induction, peri-surgical management, non-severe hemophilia, and the aging hemophilia population.